Deregulated KLF4 Expression in Myeloid Leukemias Alters Cell Proliferation and Differentiation through MicroRNA and Gene Targets

• Published in: Molecular and cellular biology Vol. 36; no. 4; pp. 559 - 573
• Main Authors: Morris, Valerie A., Cummings, Carrie L., Korb, Brendan, Boaglio, Sean, Oehler, Vivian G.
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis 01-02-2016; American Society for Microbiology
• Subjects: Base Sequence; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21 - genetics; Gene Expression Regulation, Leukemic; Humans; Kruppel-Like Transcription Factors - genetics; Leukemia, Myeloid - genetics; Leukemia, Myeloid - pathology; MicroRNAs - genetics; Molecular Sequence Data; Promoter Regions, Genetic
• ISSN: 1098-5549; 0270-7306; 1098-5549
• DOI: 10.1128/MCB.00712-15

Acute myeloid leukemia (AML) is characterized by increased proliferation and blocked differentiation of hematopoietic progenitors mediated, in part, by altered myeloid transcription factor expression. Decreased Krüppel-like factor 4 (KLF4) expression has been observed in AML, but how decreased KLF4 contributes to AML pathogenesis is largely unknown. We demonstrate decreased KLF4 expression in AML patient samples with various cytogenetic aberrations, confirm that KLF4 overexpression promotes myeloid differentiation and inhibits cell proliferation in AML cell lines, and identify new targets of KLF4. We have demonstrated that microRNA 150 (miR-150) expression is decreased in AML and that reintroducing miR-150 expression induces myeloid differentiation and inhibits proliferation of AML cells. We show that KLF family DNA binding sites are necessary for miR-150 promoter activity and that KLF2 or KLF4 overexpression induces miR-150 expression. miR-150 silencing, alone or in combination with silencing of CDKN1A, a well-described KLF4 target, did not fully reverse KLF4-mediated effects. Gene expression profiling and validation identified putative KLF4-regulated genes, including decreased MYC and downstream MYC-regulated gene expression in KLF4-overexpressing cells. Our findings indicate that decreased KLF4 expression mediates antileukemic effects through regulation of gene and microRNA networks, containing miR-150, CDKN1A, and MYC, and provide mechanistic support for therapeutic strategies increasing KLF4 expression.